Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Open Trial of Attention and Interpretation Modification (AIM) for Anxiety Disorders in Primary Care

NCT02266446 is registered in ClinicalTrials.gov with Brown University as lead sponsor.

NCT NCT02266446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02266446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Open Trial of Attention and Interpretation Modification (AIM) for Anxiety Disorders in Primary Care
Lead sponsor
Brown University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
December 31, 2015
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders